MedPath

Coronary CT Angiography in Aneurysms Repaired With Open or Endovascular Approach

Completed
Conditions
Complex Aortic Surgery
Interventions
Other: contrast CTA of the CAP
Registration Number
NCT01211548
Lead Sponsor
The Cleveland Clinic
Brief Summary

This proposal is for the pilot study that will inform the conduct of a larger prospective randomized controlled trial to guide perioperative work up and the cost/utility of CTCA (high definition CT coronary angiography.)

Detailed Description

This proposal is for a pilot study that will inform the conduct of a prospective, blinded randomized controlled trial designed to determine the cost effectiveness of an algorithm for pre operative cardiac risk stratification that uses coronary CT angiography. In addition perioperative and long-term cardiac event rate will be recorded to determine if there is any difference in these rates between the 2 groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • patients being considered for a complex aortic surgery and undergoing medically indicated contrast enhanced CT aortic angiography of the chest abdomen and pelvis
Exclusion Criteria
  • Patients with contraindications to undergoing CT coronary angiography
  • coronary revascularization within the last six months
  • renal dysfunction in whom the treating physician has decided a contrast enhanced CT scan is not warranted as part of the routine clinical work up

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
contrast CTA of the CAPcontrast CTA of the CAPAll patients being considered for a complex aortic surgery and undergoing medically indicated contrast enhanced CT aortic angiography of the chest abdomen and pelvis will be includedRaw data from CT coronary angiography will be available from all patients.
Primary Outcome Measures
NameTimeMethod
The primary outcome for the pilot study will be to assess feasibility of processes as set out in the specific aims.6 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath